AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 175 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.52 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $33,000 | -15.4% | 2,854 | +6.3% | 0.00% | – |
| Q2 2020 | $39,000 | -59.8% | 2,685 | -33.3% | 0.00% | – |
| Q1 2020 | $97,000 | 0.0% | 4,024 | 0.0% | 0.00% | – |
| Q4 2019 | $97,000 | +44.8% | 4,024 | +15.1% | 0.00% | – |
| Q3 2019 | $67,000 | -17.3% | 3,496 | +26.7% | 0.00% | – |
| Q2 2019 | $81,000 | -67.1% | 2,760 | -46.7% | 0.00% | -100.0% |
| Q1 2019 | $246,000 | +92.2% | 5,180 | +44.9% | 0.00% | 0.0% |
| Q4 2018 | $128,000 | -63.2% | 3,575 | -36.9% | 0.00% | 0.0% |
| Q3 2018 | $348,000 | +32.8% | 5,663 | +46.1% | 0.00% | 0.0% |
| Q2 2018 | $262,000 | +523.8% | 3,876 | +442.9% | 0.00% | – |
| Q1 2018 | $42,000 | 0.0% | 714 | 0.0% | 0.00% | – |
| Q4 2017 | $42,000 | – | 714 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |